诺和诺德称司美格鲁肽能缓解“食物噪音”,近半数患者摆脱饮食执念

第一财经
Sep 20, 2025

当地时间9月19日,在奥地利维也纳召开的2025年欧洲糖尿病研究协会(EASD)年会上,诺和诺德公布了在美国开展的针对使用司美格鲁肽减重药(商品名:诺和盈)患者的一项真实世界调研结果。该调研显示,在接受诺和盈治疗后,受访者经历的“食物噪音”明显减少,46%患者摆脱了饮食执念。所谓的“食物噪音”(food noise)是指难以自控、持续不断的关于食物的想法。“食物噪音”会对超重或肥胖患者的心理健康、...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10